209 related articles for article (PubMed ID: 25359276)
1. Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.
Cassidy S; Mukherjee S; Myint TM; Mbiribindi B; North H; Traherne J; Mulder A; Claas FH; Purbhoo MA; Das J; Khakoo SI
Eur J Immunol; 2015 Feb; 45(2):492-500. PubMed ID: 25359276
[TBL] [Abstract][Full Text] [Related]
2. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
3. KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles.
Bari R; Thapa R; Bao J; Li Y; Zheng J; Leung W
Sci Rep; 2016 Mar; 6():23689. PubMed ID: 27030405
[TBL] [Abstract][Full Text] [Related]
4. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
6. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
[TBL] [Abstract][Full Text] [Related]
7. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
[TBL] [Abstract][Full Text] [Related]
8. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
[TBL] [Abstract][Full Text] [Related]
9. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
Roberts CH; Molina S; Makalo P; Joof H; Harding-Esch EM; Burr SE; Mabey DC; Bailey RL; Burton MJ; Holland MJ
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2744. PubMed ID: 24651768
[TBL] [Abstract][Full Text] [Related]
11. Stable Frequencies of HLA-C
Ziegler MC; Grañana FB; Garcia-Beltran WF; Schulze Zur Wiesch J; Hoffmann C; Rechtien A; Lunemann S; Altfeld M
Front Immunol; 2018; 9():2361. PubMed ID: 30386333
[TBL] [Abstract][Full Text] [Related]
12. HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2
Wauquier N; Petitdemange C; Tarantino N; Maucourant C; Coomber M; Lungay V; Bangura J; Debré P; Vieillard V
EBioMedicine; 2019 Feb; 40():605-613. PubMed ID: 30711514
[TBL] [Abstract][Full Text] [Related]
13. Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.
Moradi S; Stankovic S; O'Connor GM; Pymm P; MacLachlan BJ; Faoro C; Retière C; Sullivan LC; Saunders PM; Widjaja J; Cox-Livingstone S; Rossjohn J; Brooks AG; Vivian JP
Nat Commun; 2021 Apr; 12(1):2173. PubMed ID: 33846289
[TBL] [Abstract][Full Text] [Related]
14. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.
Hollenbach JA; Ladner MB; Saeteurn K; Taylor KD; Mei L; Haritunians T; McGovern DP; Erlich HA; Rotter JI; Trachtenberg EA
Immunogenetics; 2009 Oct; 61(10):663-71. PubMed ID: 19789864
[TBL] [Abstract][Full Text] [Related]
16. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
Falco M; Romeo E; Marcenaro S; Martini S; Vitale M; Bottino C; Mingari MC; Moretta L; Moretta A; Pende D
J Immunol; 2010 Jul; 185(1):433-41. PubMed ID: 20525888
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.
Körner C; Granoff ME; Amero MA; Sirignano MN; Vaidya SA; Jost S; Allen TM; Rosenberg ES; Altfeld M
Eur J Immunol; 2014 Oct; 44(10):2938-48. PubMed ID: 25043727
[TBL] [Abstract][Full Text] [Related]
19. Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease.
Díaz-Peña R; Vidal-Castiñeira JR; Moro-García MA; Alonso-Arias R; Castro-Santos P
Hum Immunol; 2016 Jan; 77(1):104-109. PubMed ID: 26542067
[TBL] [Abstract][Full Text] [Related]
20. Peptide antagonism as a mechanism for NK cell activation.
Fadda L; Borhis G; Ahmed P; Cheent K; Pageon SV; Cazaly A; Stathopoulos S; Middleton D; Mulder A; Claas FH; Elliott T; Davis DM; Purbhoo MA; Khakoo SI
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10160-5. PubMed ID: 20439706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
